
Recently, Curaleaf Holdings, Inc. (CSE:CURA) (OTCQX:CURLF) reported its financial and operating results for the second quarter, ended June 30, 2022.
"Our record-breaking second quarter got off to a great start with the launch of adult use in New Jersey and a historic 4/20," said Boris Jordan, executive chairman of Curaleaf. "We bounced back from earlier headwinds to grow revenue 8%, and AEBITDA 18% sequentially while continuing to execute on our growth strategy for Europe, a key differentiator for Curaleaf and a significant advantage over our competitors.”